LASP1 and pancreatic neoplasm: To determine whether miR-218-5p was involved in ANLN-induced LASP1 expression and pancreatic cancer cell growth, migration and invasion, miR-218-5p inhibitor (anti-miR-218) was used to reverse the expression of miR-218-5p upregulation caused by ANLN knockdown.